Exploring the Impact of Once-Daily OROS® Methylphenidate (MPH) on Symptoms and Quality of Life in Children and Adolescents with ADHD Transitioning from Immediate-Release MPH
Stable isotope methodology for studying the performance of metoprolol Oros tablets in comparison to conventional and slow release formulations